Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5,588 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exosomes in Head and Neck Squamous Cell Carcinoma.
Xiao C, Song F, Zheng YL, Lv J, Wang QF, Xu N. Xiao C, et al. Among authors: xu n. Front Oncol. 2019 Sep 18;9:894. doi: 10.3389/fonc.2019.00894. eCollection 2019. Front Oncol. 2019. PMID: 31620359 Free PMC article. Review.
90-gene signature assay for tissue origin diagnosis of brain metastases.
Zheng Y, Ding Y, Wang Q, Sun Y, Teng X, Gao Q, Zhong W, Lou X, Xiao C, Chen C, Xu Q, Xu N. Zheng Y, et al. Among authors: xu n, xu q. J Transl Med. 2019 Oct 1;17(1):331. doi: 10.1186/s12967-019-2082-1. J Transl Med. 2019. PMID: 31570099 Free PMC article.
Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial.
Jiang H, Zheng Y, Qian J, Mao C, Xu X, Li N, Xiao C, Wang H, Teng L, Zhou H, Wang S, Zhu D, Peng B, Shen L, Xu N. Jiang H, et al. Among authors: xu n, xu x. BMC Cancer. 2020 Aug 14;20(1):760. doi: 10.1186/s12885-020-07251-z. BMC Cancer. 2020. PMID: 32795349 Free PMC article. Clinical Trial.
Efficacy and safety of sintilimab in combination with chemotherapy in previously untreated advanced or metastatic nonsquamous or squamous NSCLC: two cohorts of an open-label, phase 1b study.
Jiang H, Zheng Y, Qian J, Mao C, Xu X, Li N, Xiao C, Wang H, Teng L, Zhou H, Wang S, Zhu D, Sun T, Yu Y, Guo W, Xu N. Jiang H, et al. Among authors: xu n, xu x. Cancer Immunol Immunother. 2021 Mar;70(3):857-868. doi: 10.1007/s00262-020-02738-x. Epub 2020 Oct 17. Cancer Immunol Immunother. 2021. PMID: 33070260 Free PMC article. Clinical Trial.
Assessment of TMB, PD-L1, and lymphocyte to monocyte ratio as predictive potential in a phase Ib study of sintilimab in patients with advanced solid tumors.
Jiang H, Li N, Wang H, Chen Z, Zheng Y, Qian J, Mao C, Xu X, Xiao C, Zhang X, Zhou H, Wang S, Chen W, Yin X, Sun J, Peng B, Teng L, Xu N. Jiang H, et al. Among authors: xu n, xu x. Am J Cancer Res. 2021 Sep 15;11(9):4259-4276. eCollection 2021. Am J Cancer Res. 2021. PMID: 34659886 Free PMC article.
5,588 results